RC365 Holding CEO Michael Law discusses rapid growth and future plans

Cloud PR Wire
–News Direct– RC365 Holding PLC (LSE:RCGH) has made significant progress in 2024, according to CEO Michael Law, in an interview with Proactive's Stephen Gunnion. The company has transitioned 100% of its office operations, including finance, IT, and customer service, to Malaysia and Indonesia, hiring over ten new staff members in the region. RC365 has also won substantial contracts in Japan and secured a 100,000 grant from the Hong Kong Trade and Industry Department to further expand operations in Malaysia. Furthermore, RC365 agreed to 4 million in loan notes to fund upgrades and enhance its platform, focusing on services like virtual banking. The company's presence in Japan has particularly grown with a contract worth 600,000 aimed at integrating their services into local...

Poolbeg Pharma’s POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office

Cloud PR Wire
–News Direct– Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) chief legal officer John McEvoy joins Proactive's Stephen Gunnion with news that POLB 001's Immuno-modulator II has received the fully granted patent from the US Patent Office. McEvoy explained the patent encompasses a class of drugs for treating and preventing hypercytokinemia (cytokine storms) in patients triggered by an immune response, applicable across multiple disease indications. The granted patent further solidifies Poolbeg Pharma's robust intellectual property portfolio for POLB 001, potentially increasing the asset's value and making it more attractive to potential partners. McEvoy highlighted the company's ongoing efforts to strengthen and expand their IP portfolio, noting existing...

Faron Pharmaceuticals’ new CEO Dr Juho Jalkanen sets bold vision for 2024

Cloud PR Wire
–News Direct– Faron Pharmaceuticals Limited (AIM:FARN) new CEO Dr Juho Jalkanen joined Proactive's Stephen Gunnion with his vision for the company. The founding member and former chief operating officer of Faron said one of his priorities is to meet with the US Food & Drug Administration earlier than planned in the hope of fast-tracking its lead drug, bexmarilimab, which has shown huge promise in treating a type of rare blood cancer. The move follows promising data from the phase I trials involving patients with myelodysplastic syndrome (MDS) who were unresponsive to a class of drugs called hypomethylating agents (HMAs). Jalkanen highlighted the company's ongoing phase 2 trial targeting relapsed refractory MDS, emphasising the strategic goal of securing non-diluti...

Iofina’s strategic success: revenue surpasses $50 million, expansion underway

Cloud PR Wire
–News Direct– Iofina PLC (AIM:IOF, OTC:IOFNF) CEO Dr Tom Becker takes Proactive's Stephen Gunnion through the company's 2023 full-year performance, which marked another record. Iofina achieved its first-ever revenue exceeding $50 million, marking the sixth consecutive year of growth, a roughly 18% increase from the previous year, with EBITDA at $10.8 million. Becker attributed the growth to effective company strategies but noted challenges like increased input costs due to rising prices of chemicals used in their iodine extraction processes. He anticipates these costs will not escalate as sharply moving forward. Despite a slightly lower realised iodine price in 2023 compared to 2022, the market remains strong, particularly driven by demand for X-ray contrast media. Becker...

Electric Guitar debuts on AIM with big plans following 3radical acquisition

Cloud PR Wire
–News Direct– Electric Guitar PLC (AIM:ELEG) CEO John Regan spoke to Proactive's Stephen Gunnion following the company's listing on London's AIM market following the reverse takeover of 3radical. Regan emphasized Electric Guitar's "buy and build" strategy, which involves acquiring complementary businesses to enhance their market position. Despite the challenging market conditions, the company managed to complete its IPO on AIM, a testament to its team's strength and compelling business proposition. 3radical specialises in collecting first-party dataa valuable asset in today's privacy-focused advertising market. This acquisition marks Electric Guitar's entry into the technical side of the advertising industry, respond...

ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant

Cloud PR Wire
–News Direct– ANGLE PLC chief executive Andrew Newland joins Proactive's Stephen Gunnion with details of a supplier agreement with AstraZeneca PLC to develop an androgen receptor (AR) detection assay to enhance prostate cancer studies. With a contract value of 550,000, the project is scheduled for completion in the first quarter of next year. Newland said the agreement is an extension of a prior arrangement to develop a methodology for detecting CTC micronuclei and will use ANGLE's innovative Parsortix system. Successful development of this AR assay is expected to bolster the use of the Parsortix system in clinical oncology, particularly for assessing the efficacy of prostate cancer therapies. The discussion also touched upon the potential benefits of this development fo...

HIVE Digital Technologies CEO Aydin Kilic discusses strategic growth in AI and crypto mining

Cloud PR Wire
–News Direct– HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) president and CEO Aydin Kilic joined Stephen Gunnion in Proactive's London studio with insights into the companys transition and growth. Initially established as the first publicly traded crypto mining company in 2017, HIVE began by mining Ethereum in Iceland before expanding to Sweden and Canada. Following Ethereum's transition during the merge, HIVE pivoted its GPU resources from Ethereum to Bitcoin mining and later to AI computing. This strategic shift has proven profitable, with the AI computing segment achieving a $1 million annual run rate in its initial beta test phase and growing to an almost $10 million Internal Rate of Return (IRR) in the subsequent year. Kilic also discussed the operational diffe...

PRESTIGEPEO WINS TWO STEVIE AWARDS IN 2024 AMERICAN BUSINESS AWARDS

Cloud PR Wire
–News Direct– PrestigePEO, one of the nations largest professional employer organizations (PEO), announced today it was named winner of two Bronze Stevie Awards in both the Company of the Year – Business & Professional Services Medium and Achievement in Sales or Revenue Generation categories of The 22nd Annual American Business Awards. The American Business Awards are the U.S.A.s premier business awards program. All organizations operating in the U.S.A. are eligible to submit nominations public and private, for-profit and non-profit, large and small. Nicknamed the Stevies for the Greek word meaning crowned, the awards will be presented to winners at a gala ceremony at the Marriott Marquis Hotel in New York on Tuesday, June 11. Tickets are now on sale. PrestigePEO was recognized ...

Team Internet CEO Michael Riedl discusses growth and integration post-Shinez acquisition

Cloud PR Wire
–News Direct– Team Internet Group PLC (AIM:TIG, OTCQX:TIGXF) CEO Michael Riedl discusses the completion of the acquisition of Shinez, a digital content production and promotion company specialising in listicle-based articles with embedded advertisements. Riedl noted that the acquisition is immediately accretive to earnings, with an expected high single-digit EPS accretion for the year, even before accounting for synergies. He highlighted that Shinez attracts different customer groups early in the decision-making process, which complements Team Internet's existing product suite. With the inclusion of Shinez, Team Internet now covers the entire marketing conversion funnel, from initial awareness to final sale conversions, he added. Riedl also discussed future growth strategies, em...

Axmed raises $2 million to transform access to critical medicines in low and middle income countries

Cloud PR Wire
–News Direct– For too long, low- and middle-income countries (LMICs) have borne the brunt of global health disparitiesaccounting for over 80% of the world's population and more than 90% of its disease burdenyet representing a mere 6% of global pharmaceutical revenue. Equitable access to high quality affordable medicines remains a daunting task, and addressing this challenge has never been more critical. Axmed, an innovative two-sided B2B marketplace platform, is taking a bold and meaningful step forward in addressing this disparity with the announcement of a $2 million seed funding round. This investment aims to accelerate the affordability, availability, and distribution of essential and innovative medicines in underserved regions. The fresh investment was led by Founderful and c...